Robert Jr. Leasure Sells 22,700 Shares of Inotiv, Inc. (NASDAQ:NOTV) Stock

Inotiv, Inc. (NASDAQ:NOTV) CEO Robert Jr. Leasure sold 22,700 shares of Inotiv stock in a transaction dated Friday, January 31st. The shares were sold at an average price of $4.15, for a total transaction of $94,205.00. Following the transaction, the chief executive officer now owns 1,030,209 shares of the company’s stock, valued at $4,275,367.35. This represents a 2.16 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Inotiv Stock Down 6.9 %

NOTV stock opened at $4.18 on Thursday. The stock’s 50 day moving average is $4.43 and its 200-day moving average is $2.80. Inotiv, Inc. has a twelve month low of $1.23 and a twelve month high of $11.42. The firm has a market capitalization of $108.72 million, a PE ratio of -1.00 and a beta of 3.58. The company has a quick ratio of 1.22, a current ratio of 1.37 and a debt-to-equity ratio of 2.29.

Inotiv (NASDAQ:NOTV) last posted its quarterly earnings data on Wednesday, February 5th. The company reported ($0.42) EPS for the quarter, missing the consensus estimate of ($0.32) by ($0.10). Inotiv had a negative net margin of 22.10% and a negative return on equity of 15.86%. Sell-side analysts expect that Inotiv, Inc. will post -0.75 EPS for the current fiscal year.

Hedge Funds Weigh In On Inotiv

Institutional investors have recently added to or reduced their stakes in the stock. Renaissance Technologies LLC grew its holdings in Inotiv by 29.9% during the second quarter. Renaissance Technologies LLC now owns 164,164 shares of the company’s stock valued at $273,000 after purchasing an additional 37,800 shares during the period. Geode Capital Management LLC increased its position in shares of Inotiv by 7.7% during the 3rd quarter. Geode Capital Management LLC now owns 250,895 shares of the company’s stock valued at $427,000 after purchasing an additional 18,039 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. raised its stake in shares of Inotiv by 612.5% during the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 127,257 shares of the company’s stock worth $527,000 after acquiring an additional 109,397 shares in the last quarter. KPP Advisory Services LLC raised its position in Inotiv by 15.8% in the 4th quarter. KPP Advisory Services LLC now owns 275,267 shares of the company’s stock worth $1,140,000 after purchasing an additional 37,549 shares during the period. Finally, Vantage Point Financial LLC bought a new stake in shares of Inotiv in the 4th quarter valued at about $1,393,000. Institutional investors own 18.17% of the company’s stock.

Inotiv Company Profile

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.